共 151 条
- [1] Jemal A(2009)Cancer statistics: 2009 CA Cancer J Clin 59 225-249
- [2] Siegel R(1998)Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists’ Group Br J Cancer 78 1479-1487
- [3] Ward E(2006)Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 34-43
- [4] Hao Y(1991)Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience J Clin Oncol 9 1138-1150
- [5] Xu J(2004)PET–CT in recurrent ovarian cancer: initial observations Radio Gr 24 209-223
- [6] Thun MJ(1995)Ovarian cancer recurrence: value of MR imaging Radiology 196 715-720
- [7] Aabo K(2004)Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings Radiology 233 433-440
- [8] Adams M(2009)Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system Eur J Obstet Gynecol Reprod Biol 143 69-74
- [9] Adnitt P(2006)Carcinoma of the ovary: FIGO 6th annual report on the results of treatment in gynecological cancer Int J Gynaecol Obstet 95 S161-S192
- [10] Armstrong DK(2002)Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer AJR Am J Roentgenol 179 391-395